DB
EHC icon

Dmitry Balyasny’s Encompass Health EHC Stock Holding History

Dmitry Balyasny’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-150,000
Closed -$10.2M – 2367
2023
Q2 		$10.2M Buy
+150,000
New +$9.4M 0.02% 768
2018
Q1 		– Sell
-99,806
Closed -$3.92M – 2026
2017
Q4 		$3.92M Buy
+99,806
New +$3.8M 0.01% 937

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dmitry Balyasny's EHC Position: Q2 2026 in Review

Dmitry Balyasny increased its Encompass Health (EHC) stake by 451% in Q2 2026, buying an estimated $25.2M and bringing the position to 296,939 shares worth $30M. The position accounts for 0.04% of the portfolio, ranked #545.

Dmitry Balyasny first reported a position in EHC in Q1 2015 and has held it in 32 quarters since. The position peaked at $40.5M in Q4 2025. 594 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Dmitry Balyasny held 296,939 shares of Encompass Health worth $30M as of Q2 2026.
  • Dmitry Balyasny bought 243,080 Encompass Health shares in Q2 2026, an estimated $25.2M.
  • Encompass Health made up 0.04% of Dmitry Balyasny's portfolio in Q2 2026, its #545 holding.
  • Dmitry Balyasny first reported a position in Encompass Health in Q1 2015 and has held it in 32 quarters since.
  • Dmitry Balyasny's Encompass Health position peaked at $40.5M in Q4 2025.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.